Business
PURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA
PURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n \n PURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA\n \n \nPURE Bioscience Unveiled PURE Control(R) at 2016 IPPE in Atlanta, GA\n\nFDA Approved PURE Control Antimicrobial Poultry Processing Aid Introduced as Non-Toxic Intervention to Dramatically Reduce Salmonella\n\n \n SAN DIEGO, CA--(Marketwired - Feb 1, 2016) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial, announced that the Company introduced PURE Control® at IPPE (International Production & Processing Expo) last week. IPPE is the world's largest annual poultry, meat and feed industry event attended by more than 30,000 industry leaders and their suppliers seeking to learn about the latest technological developments in the industry.\n PURE Control is a leading-edge antimicrobial processing aid for direct application to poultry during processing to reduce pathogen populations. It maximizes microbial control and is highly effective against Salmonella, Listeria, E. coli and many other pathogens. SDC test results show the potential to reduce Salmonella on raw poultry to below detection levels.\n Since receiving recent validation from its two FDA approvals (for fresh produce processing and for raw poultry processing), PURE Control is generating significant interest from both processors and distributors who are evaluating bringing in PURE Control as a processing aid. This is opening up a combined processing aid market opportunity in excess of $650 million, of which PURE expects to gain a significant share based on SDC's compelling competitive advantages.\n The final step in the regulatory approval process for PURE Control for poultry processing is to obtain USDA approval. The approval process will involve plant trials under the authorization of the USDA which are expected to be completed by early calendar Q2. PURE will then begin immediate commercialization.\n Expo Meetings Highlights\n Throughout the Expo, the PURE team had a series of productive meetings with many of the leading poultry processors and their chemical distributors:\n \n \n Processors at the show emphasized to PURE that the persistence of Salmonella and Campylobacter remains their biggest challenge, and expressed keen interest in bringing PURE Control into their plants following the successful completion o...